NCT07663266 Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury
| NCT ID | NCT07663266 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 14 participants |
| Start Date | 2026-05-25 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 14 participants in total. It began in 2026-05-25 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Just-In-Time Adaptive Interventions (JITAIs) offer a framework for delivering personalized behavioral support using time-varying data to optimize the timing and type of intervention content. This project will develop the foundational components of a JITAI tailored to adults with chronic pain and either MS or SCI by drawing on symptom self-management content from existing programs (PainGuide, MyMSToolkit, and MySCIToolkit). Intervention content and delivery parameters will be refined through stakeholder engagement via structured interviews to ensure relevance, acceptability, and feasibility.
Eligibility Criteria
Inclusion Criteria: * Able to read and converse fluently in English * Multiple sclerosis (MS) or Spinal Cord Injury (SCI) diagnosis * Chronic pain ( ≥ 4 on average using a 0-10 NRS for 3-month duration) * Access to an internet connected device with a camera and microphone for participating in virtual interview/focus group. Exclusion Criteria: * Cognitive or other impairment (e.g., hearing) that precludes study participation.
Contact & Investigator
Anna Kratz
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT07663266 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07663266 currently recruiting?
Yes, NCT07663266 is actively recruiting participants. Contact the research team at knpicku@med.umich.edu for enrollment information.
Where is the NCT07663266 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT07663266 clinical trial?
NCT07663266 is sponsored by University of Michigan. The principal investigator is Anna Kratz at University of Michigan. The trial plans to enroll 14 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.